{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:29:13Z","timestamp":1792214953906,"version":"4.4.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijbiomac.2025.142861","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T12:36:24Z","timestamp":1743942984000},"page":"142861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"P1","title":["Nose-to-brain delivery of sorafenib-loaded lipid-based poloxamer-carrageenan nanoemulgel: Formulation and therapeutic investigation in glioblastoma-induced orthotopic rat model"],"prefix":"10.1016","volume":"309","author":[{"given":"Shubham","family":"Khot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unmesh","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajakta","family":"Vaishampayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uddhav","family":"Bagul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dnyandev","family":"Gadhave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bapi","family":"Gorain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrakant","family":"Kokare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.142861_bb0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40001-023-01011-y","article-title":"The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis","volume":"28","author":"Salari","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.614930","article-title":"The subventricular zone, a hideout for adult and pediatric high-grade glioma stem cells","volume":"10","author":"Lombard","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3857\/roj.2020.00591","article-title":"Clinical behaviour and outcome in pediatric glioblastoma: current scenario","volume":"39","author":"Singla","year":"2021","journal-title":"Radiat. Oncol. J."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0020","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2174\/1570159X19666210113152108","article-title":"Targeting glioblastoma: the current state of different therapeutic approaches","volume":"19","author":"Khan","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2023.05.012","article-title":"Temozolomide-fatty acid conjugates for glioblastoma multiforme: In vitro and in vivo evaluation","volume":"359","author":"Jatyan","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0030","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3389\/fneur.2020.01036","article-title":"Carmustine as a supplementary therapeutic option for glioblastoma: a systematic review and Meta-analysis","volume":"11","author":"Xiao","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","article-title":"Glioma targeted therapy: insight into future of molecular approaches","volume":"21","author":"Yang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/pharmaceutics16010100","article-title":"Targeted glioma therapy\u2014clinical trials and future directions","volume":"16","author":"Shikalov","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0045","first-page":"240","article-title":"PharmGKB summary: sorafenib pathways, Pharmacogenet","volume":"27","author":"Gong","year":"2017","journal-title":"Genomics"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0050","doi-asserted-by":"crossref","unstructured":"H. Chen, J. Kuhn, K.R. Lamborn, L.E. Abrey, L.M. DeAngelis, F. Lieberman, H.I. Robins, S.M. Chang, W.K.A. Yung, J. Drappatz, M.P. Mehta, V.A. Levin, K. Aldape, J.E. Dancey, J.J. Wright, M.D. Prados, T.F. Cloughesy, P.Y. Wen, M.R. Gilbert, Phase I\/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05\u201302, Neuro-Oncol. Adv. 2 (2020) vdaa124. doi:https:\/\/doi.org\/10.1093\/noajnl\/vdaa124.","DOI":"10.1093\/noajnl\/vdaa124"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0055","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1158\/1078-0432.CCR-13-0708","article-title":"Phase II study of bevacizumab in combination with Sorafenib in recurrent glioblastoma (N0776): a north central Cancer treatment group trial","volume":"19","author":"Galanis","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1021\/acs.molpharmaceut.5b00837","article-title":"Improving Oral bioavailability of Sorafenib by optimizing the \u201cspring\u201d and \u201cparachute\u201d based on molecular interaction mechanisms","volume":"13","author":"Liu","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0065","first-page":"3475","article-title":"Sorafenib increases tumor treating fields-induced cell death in glioblastoma by inhibiting STAT3","volume":"10","author":"Kim","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0070","doi-asserted-by":"crossref","unstructured":"H. Chen, J. Kuhn, K.R. Lamborn, L.E. Abrey, L.M. DeAngelis, F. Lieberman, H.I. Robins, S.M. Chang, W.K.A. Yung, J. Drappatz, M.P. Mehta, V.A. Levin, K. Aldape, J.E. Dancey, J.J. Wright, M.D. Prados, T.F. Cloughesy, P.Y. Wen, M.R. Gilbert, Phase I\/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05\u201302, Neuro-Oncol. Adv. 2 (2020) vdaa124. doi:https:\/\/doi.org\/10.1093\/noajnl\/vdaa124.","DOI":"10.1093\/noajnl\/vdaa124"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0075","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/neuonc\/nox175","article-title":"Is the blood\u2013brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data","volume":"20","author":"Sarkaria","year":"2018","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0080","doi-asserted-by":"crossref","unstructured":"M. Veleti\u0107, M.T. Barros, I. Balasingham, S. Balasubramaniam, A molecular communication model of exosome-mediated brain drug delivery, in: Proc. Sixth Annu. ACM Int. Conf. Nanoscale Comput. Commun., ACM, Dublin Ireland, 2019: pp. 1\u20137. doi:https:\/\/doi.org\/10.1145\/3345312.3345478.","DOI":"10.1145\/3345312.3345478"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0085","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1369\/0022155421994679","article-title":"Immunohistochemical detection of neural stem cells and glioblastoma stem cells in the subventricular zone of glioblastoma patients","volume":"69","author":"Hira","year":"2021","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.pneurobio.2015.10.005","article-title":"Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: methylene blue connects the dots","volume":"157","author":"Yang","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0095","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/jpm11060571","article-title":"Recent advances in tumor targeting via EPR effect for Cancer treatment","volume":"11","author":"Subhan","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1021\/acs.bioconjchem.8b00732","article-title":"The endosomal escape of nanoparticles: toward more efficient cellular delivery","volume":"30","author":"Smith","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0105","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/pharmaceutics14030588","article-title":"Strategies to improve drug strength in nasal preparations for brain delivery of low aqueous solubility drugs","volume":"14","author":"Pires","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0110","unstructured":"T.C. Chen, C.O. da Fonseca, A.H. Sch\u00f6nthal, Bringing intranasal drug delivery for malignancies in the brain to market, expert Opin. Drug Deliv. (2025). https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/17425247.2025.2464714 (accessed March 24, 2025)."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0115","doi-asserted-by":"crossref","first-page":"1214450","DOI":"10.3389\/fcell.2023.1214450","article-title":"Lipid-based nanoparticles via nose-to-brain delivery: a mini review","volume":"11","author":"Xinchen","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0120","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","article-title":"Nanoemulsion: concepts, development and applications in drug delivery","volume":"252","author":"Singh","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0125","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.msec.2016.05.121","article-title":"Polysaccharide based nanogels in the drug delivery system: application as the carrier of pharmaceutical agents","volume":"68","author":"Debele","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0130","series-title":"Polysaccharides of the Red Algae, in: Adv","first-page":"115","author":"Usov","year":"2011"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0135","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/gels9060491","article-title":"Propranolol-loaded limonene-based microemulsion Thermo-responsive Mucoadhesive nasal Nanogel: design, In Vitro Assessment, Ex Vivo Permeation, and Brain Biodistribution","volume":"9","author":"Abla","year":"2023","journal-title":"Gels"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2014.08.023","article-title":"Enhancement in bioavailability of ketorolac tromethamine via intranasal in situ hydrogel based on poloxamer 407 and carrageenan","volume":"474","author":"Li","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0145","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3390\/pharmaceutics13081216","article-title":"Ion-triggered in situ gelling Nanoemulgel as a platform for nose-to-brain delivery of small lipophilic molecules","volume":"13","author":"Nagaraja","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4169","article-title":"Development of a validated liquid chromatographic method for quantification of sorafenib tosylate in the presence of stress-induced degradation products and in biological matrix employing analytical quality by design approach","volume":"32","author":"Sharma","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jpba.2007.10.030","article-title":"Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound","volume":"46","author":"Baka","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0160","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/acs.jced.6b00630","article-title":"Solubility correlation and thermodynamic analysis of Sorafenib Free Base and Sorafenib Tosylate in Monosolvents and binary solvent mixtures","volume":"62","author":"Jiang","year":"2017","journal-title":"J. Chem. Eng. Data"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0165","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.xphs.2016.03.019","article-title":"An overview of pharmaceutical excipients: safe or not safe?","volume":"105","author":"Abrantes","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0170","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1021\/acs.jced.0c00341","article-title":"Effect of a nonionic surfactant on the Pseudoternary phase diagram and stability of microemulsion","volume":"65","author":"Gunarto","year":"2020","journal-title":"J. Chem. Eng. Data"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0175","first-page":"839","article-title":"Supersaturated LFCS type III self-emulsifying delivery systems of sorafenib tosylate with improved biopharmaceutical performance: QbD-enabled development and evaluation, drug Deliv","volume":"10","author":"Sharma","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0180","doi-asserted-by":"crossref","first-page":"34746","DOI":"10.1021\/acsomega.3c03713","article-title":"Hansen solubility parameters and QbD-oriented HPLC method development and validation for Dermatokinetic study of a miconazole-loaded cationic Nanoemulsion in rat model","volume":"8","author":"Hussain","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0185","doi-asserted-by":"crossref","first-page":"13746","DOI":"10.1038\/s41598-022-17333-6","article-title":"Oral sorafenib-loaded microemulsion for breast cancer: evidences from the in-vitro evaluations and pharmacokinetic studies","volume":"12","author":"Chaurawal","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0190","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jddst.2019.02.013","article-title":"Intranasal teriflunomide microemulsion: an improved chemotherapeutic approach in glioblastoma","volume":"51","author":"Gadhave","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0195","first-page":"2030","article-title":"Surface-engineered nanostructured lipid carrier systems for synergistic combination oncotherapy of non-small cell lung cancer, drug Deliv","volume":"11","author":"Rawal","year":"2021","journal-title":"Transl. Res."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123746","article-title":"Fabrication of architectonic nanosponges for intraocular delivery of Brinzolamide: an insight into QbD driven optimization, in vitro characterization, and pharmacodynamics","volume":"650","author":"Bagul","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0205","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.colsurfb.2016.08.011","article-title":"Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery","volume":"147","author":"Hao","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0210","doi-asserted-by":"crossref","first-page":"13352","DOI":"10.1038\/s41598-020-70392-5","article-title":"NF-\u03baB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-\u03baB(p65) and actin cytoskeleton regulatory pathways","volume":"10","author":"Avci","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0215","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/jcb.27420","article-title":"Ivermectin inhibits the growth of glioma cells by inducing cell cycle arrest and apoptosis in vitro and in vivo","volume":"120","author":"Song","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0220","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1021\/acs.molpharmaceut.9b01215","article-title":"Nose-to-brain delivery of Cancer-targeting paclitaxel-loaded nanoparticles potentiates antitumor effects in malignant glioblastoma","volume":"17","author":"Ullah","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0225","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2017.06.032","article-title":"A potential non-invasive glioblastoma treatment: nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles","volume":"261","author":"Sekerdag","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0230","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/jpi.12358","article-title":"Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy","volume":"61","author":"Prieto-Dom\u00ednguez","year":"2016","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104470","article-title":"Chronotherapy in glioblastoma: state of the art and future perspectives","volume":"89","author":"Petkovi\u0107","year":"2023","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2013.10.011","article-title":"Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression","volume":"48","author":"Haque","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0245","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jconrel.2020.04.002","article-title":"Guidelines for the experimental design of pharmacokinetic studies with nanomaterials in preclinical animal models","volume":"323","author":"Valic","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0250","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s13318-011-0066-5","article-title":"A modified serial blood sampling technique and utility of dried-blood spot technique in estimation of blood concentration: application in mouse pharmacokinetics","volume":"37","author":"Kurawattimath","year":"2012","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120474","article-title":"Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: optimization and in vivo pharmacokinetic studies","volume":"600","author":"Patel","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0260","doi-asserted-by":"crossref","unstructured":"S.A. Abd-algaleel, A.A. Metwally, H.M. Abdel-Bar, D.H. Kassem, R.M. Hathout, Synchronizing In Silico, In Vitro, and In Vivo Studies for the Successful Nose to Brain Delivery of an Anticancer Molecule, Mol. Pharm. 18 (2021) 3763\u20133776. doi:https:\/\/doi.org\/10.1021\/acs.molpharmaceut.1c00276.","DOI":"10.1021\/acs.molpharmaceut.1c00276"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0265","doi-asserted-by":"crossref","first-page":"19815","DOI":"10.1039\/C6RA27096D","article-title":"Development and characterization of promising Cremophor EL-stabilized o\/w nanoemulsions containing short-chain alcohols as a cosurfactant","volume":"7","author":"Zeng","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0270","series-title":"Penetration Enhancers for the Development of Intranasal Formulations for Use in Equines","volume":"1","author":"Velloso","year":"2022"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112999","article-title":"Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): a current overview of active targeting in brain diseases","volume":"221","author":"Teixeira","year":"2023","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.117881","article-title":"Structural aspects of a self-emulsifying multifunctional amphiphilic excipient: part II. The case of Cremophor EL","volume":"344","author":"Jadhav","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0285","doi-asserted-by":"crossref","first-page":"63","DOI":"10.51847\/1h17TZqgyI","article-title":"Co-surfactant effect of polyethylene glycol 400 on microemulsion using BCS class II model drug","volume":"12","author":"Taher","year":"2022","journal-title":"J. Adv. Pharm. Educ. Res."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0290","article-title":"Intranasal delivery of gabapentin loaded optimized nanoemulsion for augmented permeation","volume":"56","author":"Mallick","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0295","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.17576\/jsm-2019-4805-12","article-title":"The influence of surfactant\/co-surfactant hydrophilic-lipophilic balance on the formation of limonene-based microemulsion as vitamin C carrier","volume":"48","author":"Ramli","year":"2019","journal-title":"Sains Malays."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0300","doi-asserted-by":"crossref","first-page":"11889","DOI":"10.1021\/ie102480d","article-title":"Temperature induced emulsification and Demulsification of Pseudoternary mixtures of Tween80\u2013butanol\u2013kerosene\u2013water system","volume":"50","author":"Mukherjee","year":"2011","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0305","series-title":"Risk Assessment and QbD Based Optimization of an Eprosartan Mesylate nanosuspension_ in-Vitro Characterization, PAMPA and in-Vivo Assessment","author":"Shekhawat","year":"2019"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0310","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bej.2017.11.007","article-title":"Hydrodynamic effect of dispersed phase fraction on the mass transfer and uptake rate of hexadecane by an oil-degrading microbial consortium in an airlift bioreactor","volume":"130","author":"Tec-Caamal","year":"2018","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0315","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s13202-022-01475-4","article-title":"Influencing factors and microscopic formation mechanism of phase transitions of microemulsion system","volume":"12","author":"Dongqi","year":"2022","journal-title":"J. Pet. Explor. Prod. Technol."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0320","series-title":"Sci","article-title":"Factors affecting the stability of emulsions stabilised by biopolymers","author":"Maphosa","year":"2018"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2022.100103","article-title":"Sorafenib tosylate novel drug delivery systems: implications of nanotechnology in both approved and unapproved indications","volume":"8","author":"Raut","year":"2022","journal-title":"OpenNano"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0330","series-title":"Basic Fundam. Drug Deliv.","first-page":"369","article-title":"Importance of physicochemical characterization of nanoparticles in pharmaceutical product development","author":"Raval","year":"2019"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2023\/6640103","article-title":"Nanoemulsion: an emerging novel Technology for Improving the bioavailability of drugs","volume":"2023","author":"Preeti","year":"2023","journal-title":"Scientifica"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0340","doi-asserted-by":"crossref","first-page":"18012","DOI":"10.1038\/s41598-023-43689-4","article-title":"Application of ensemble machine learning approach to assess the factors affecting size and polydispersity index of liposomal nanoparticles","volume":"13","author":"Hoseini","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0345","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1021\/acs.nanolett.0c02352","article-title":"Unhindered Brownian motion of individual nanoparticles in liquid-phase scanning transmission Electron microscopy","volume":"20","author":"Yesibolati","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0350","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/1061186X.2020.1722137","article-title":"Stability issues and approaches to stabilised nanoparticles based drug delivery system","volume":"28","author":"Sultana","year":"2020","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0355","doi-asserted-by":"crossref","unstructured":"K.-H. Lin, S.-T. Hong, H.-T. Wang, Y.-L. Lo, A. Lin, J. Yang, Enhancing Anticancer Effect of Gefitinib across the Blood\u2013Brain Barrier Model Using Liposomes Modified with One \u03b1-Helical Cell-Penetrating Peptide or Glutathione and Tween 80, Int. J. Mol. Sci. 17 (2016) 1998. doi:https:\/\/doi.org\/10.3390\/ijms17121998.","DOI":"10.3390\/ijms17121998"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0360","doi-asserted-by":"crossref","first-page":"21521","DOI":"10.1038\/s41598-020-76504-5","article-title":"Release of a liver anticancer drug, sorafenib from its PVA\/LDH- and PEG\/LDH-coated iron oxide nanoparticles for drug delivery applications","volume":"10","author":"Ebadi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0365","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s13318-020-00641-5","article-title":"Nose-to-brain delivery of diazepam from an intranasal aqua-triggered in-situ (ATIS) gelling microemulsion: monitoring brain uptake by microdialysis","volume":"45","author":"Bachhav","year":"2020","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0370","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/polym10030267","article-title":"Chitosan and its derivatives for application in Mucoadhesive drug delivery systems","volume":"10","author":"Ways","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127217","article-title":"Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine","volume":"253","author":"Hard","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0380","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.apsb.2017.03.003","article-title":"In vivo retention of poloxamer-based in situ hydrogels for vaginal application in mouse and rat models","volume":"7","author":"Liu","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0385","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.ijbiomac.2020.11.047","article-title":"Nose-to-brain delivery of teriflunomide-loaded lipid-based carbopol-gellan gum nanogel for glioma: pharmacological and in vitro cytotoxicity studies","volume":"167","author":"Gadhave","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106338","article-title":"Preparation of C6 cell membrane-coated doxorubicin conjugated manganese dioxide nanoparticles and its targeted therapy application in glioma","volume":"180","author":"Du","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0395","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.neo.2015.07.003","article-title":"Sorafenib sensitizes glioma cells to the BH3 mimetic ABT-737 by targeting MCL1 in a STAT3-dependent manner","volume":"17","author":"Kiprianova","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0400","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.3892\/ol.2016.4237","article-title":"Regulation of C6 glioma cell migration by thymol","volume":"11","author":"Lee","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0405","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jcp.22099","article-title":"Sorafenib combined vitamin K induces apoptosis in human pancreatic cancer cell lines through RAF\/MEK\/ERK and c-Jun NH2-terminal kinase pathways","volume":"224","author":"Wei","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0410","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1477-7819-10-60","article-title":"Vitamin K1 enhances sorafenib-induced growth inhibition and apoptosis of human malignant glioma cells by blocking the Raf\/MEK\/ERK pathway","volume":"10","author":"Du","year":"2012","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0415","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3390\/ijms25021067","article-title":"The TGF-\u03b2 family in glioblastoma","volume":"25","author":"Gol\u00e1n-Cancela","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.660005","article-title":"Oxidative stress activated by Sorafenib alters the Temozolomide sensitivity of human glioma cells through autophagy and JAK2\/STAT3-AIF Axis","volume":"9","author":"Wei","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0425","doi-asserted-by":"crossref","first-page":"582","DOI":"10.21873\/invivo.12741","article-title":"Combination treatment of Sorafenib and Bufalin induces apoptosis in NCI-H292 human lung Cancer cells in vitro","volume":"36","author":"Kuo","year":"2022","journal-title":"In Vivo"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0430","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.3390\/ijms19113684","article-title":"Functional biological activity of Sorafenib as a tumor-treating field sensitizer for glioblastoma therapy","volume":"19","author":"Jo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0435","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.2147\/IJN.S38927","article-title":"Antitumor efficacy of a novel CLA-PTX microemulsion against brain tumors: in vitro and in vivo findings","author":"Zhang","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0440","doi-asserted-by":"crossref","first-page":"e1030","DOI":"10.1038\/cddis.2013.557","article-title":"Pro-apoptotic Sorafenib signaling in murine hepatocytes depends on malignancy and is associated with PUMA expression in vitro and in vivo","volume":"5","author":"Sonntag","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0445","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3390\/cancers11101453","article-title":"Diclofenac potentiates Sorafenib-based treatments of hepatocellular carcinoma by enhancing oxidative stress","volume":"11","author":"Duval","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0450","doi-asserted-by":"crossref","first-page":"14222","DOI":"10.1039\/C6NR02448C","article-title":"Glioma-targeted superparamagnetic iron oxide nanoparticles as drug-carrying vehicles for theranostic effects","volume":"8","author":"Xu","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0455","doi-asserted-by":"crossref","unstructured":"F.A. Bruinsmann, A. de Cristo Soares Alves, A. de Fraga Dias, L.F. Lopes Silva, F. Visioli, A. Raffin Pohlmann, F. Figueir\u00f3, F. Sonvico, S. Stanis\u00e7uaski Guterres, Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo, Int. J. Pharm. 616 (2022) 121563. doi:https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121563.","DOI":"10.1016\/j.ijpharm.2022.121563"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0460","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/14737140.2019.1559058","article-title":"Sorafenib: key lessons from over 10 years of experience","volume":"19","author":"Escudier","year":"2019","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0465","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2147\/JHC.S304439","article-title":"Clinical characteristics of long-term survivors after Sorafenib treatment for Unresectable hepatocellular carcinoma: a Korean National Multicenter Retrospective Cohort Study","volume":"8","author":"Cho","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0470","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1158\/1535-7163.MCT-09-0663","article-title":"Breast Cancer resistance protein and P-glycoprotein limit Sorafenib brain accumulation","volume":"9","author":"Lagas","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0475","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jconrel.2011.08.017","article-title":"Transport of drugs across the blood\u2013brain barrier by nanoparticles","volume":"161","author":"Wohlfart","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0480","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2125.2011.03963.x","article-title":"Population pharmacokinetic analysis of sorafenib in patients with solid tumours","volume":"72","author":"Jain","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0485","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1007\/s10637-011-9767-5","article-title":"Plasma protein binding of sorafenib, a multi kinase inhibitor: in vitro and in cancer patients","volume":"30","author":"Villarroel","year":"2012","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0490","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00280-016-3018-6","article-title":"Sorafenib metabolism, transport, and enterohepatic recycling: physiologically based modeling and simulation in mice","volume":"77","author":"Edginton","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0495","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1631\/jzus.B1400010","article-title":"Early changes in apparent diffusion coefficient as an indicator of response to sorafenib in hepatocellular carcinoma","volume":"15","author":"Zhao","year":"2014","journal-title":"J. Zhejiang Univ.-Sci. B"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0500","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.colsurfb.2019.05.016","article-title":"Poloxamer-407 thickened lipid colloidal system of agomelatine for brain targeting: characterization, brain pharmacokinetic study and behavioral study on Wistar rats","volume":"181","author":"Ahmed","year":"2019","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0505","first-page":"817","article-title":"Lamotrigine-loaded Poloxamer-based Thermo-responsive sol\u2013gel: formulation","volume":"9","author":"Riaz","year":"2023","journal-title":"In Vitro Assessment, Ex Vivo Permeation, and Toxicology Study, Gels"},{"key":"10.1016\/j.ijbiomac.2025.142861_bb0510","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pharma.2022.08.010","article-title":"Nose-to-brain delivery of paliperidone palmitate poloxamer-guar gum nanogel: formulation, optimization and pharmacological studies in rats","volume":"81","author":"Gadhave","year":"2023","journal-title":"Ann. Pharm. Fr."}],"updated-by":[{"DOI":"10.1016\/j.ijbiomac.2026.151266","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000}},{"DOI":"10.1016\/j.ijbiomac.2026.151266","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000}}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025034130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025034130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:55:08Z","timestamp":1782903308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025034130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":102,"alternative-id":["S0141813025034130"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142861","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nose-to-brain delivery of sorafenib-loaded lipid-based poloxamer-carrageenan nanoemulgel: Formulation and therapeutic investigation in glioblastoma-induced orthotopic rat model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"142861"}}